Nifty 50
- Dr. Reddy's Labs₹1,229.4032.40 (2.71%)
- Apollo Hospitals₹7,775-252.50 (-3.15%)
- Bajaj Auto₹10,034256.00 (2.62%)
- ITC₹257.90-8.10 (-3.05%)
- Tata Motors PV₹284.454.55 (1.63%)
- Tech Mahindra₹1,471-43.10 (-2.85%)
- Bharat Electronics₹373.905.75 (1.56%)
- L&T₹3,627.50-75.80 (-2.05%)
- BSE₹3,330.2043.00 (1.31%)
- Max Healthcare₹865.95-17.85 (-2.02%)
- Cipla₹1,317.4016.40 (1.26%)
- Hindalco Industries₹882.50-17.85 (-1.98%)
- Eicher Motors₹7,11969.00 (0.98%)
- Hindustan Unilever₹1,820.70-36.00 (-1.94%)
- Mahindra & Mahindra₹2,81316.80 (0.60%)
- SBI₹941-18.10 (-1.89%)
- Kotak Mahindra Bank₹443.402.40 (0.54%)
- Coal India₹404.80-6.75 (-1.64%)
- HCL Technologies₹1,2236.30 (0.52%)
- Bharti Airtel₹1,778.70-26.40 (-1.46%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Algo Strategy
- Markets
Stocks
F&O
Mutual Funds
- More
Open Free Demat Account
Open Free Demat Account
Parmax Pharma Share Price Today
As of 13-10-2026 05:51, Parmax Pharma Ltd. share price today is ₹0, with a change of ₹-139.10 (-100.00%) from the previous close of ₹139.1. The stock opened at ₹139.1 and traded between ₹137.75 and ₹139.1, with a total traded volume of 1506 shares. The company has a market capitalization of ₹52 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹139.1 and ₹22.6, respectively.
Parmax Pharma Ltd. valuation metrics include a P/E ratio of -43.5, and book value of ₹-11.20. Parmax Pharma Ltd. has reported revenue of ₹18.39 Cr and net profit of ₹-1.2 Cr.
Parmax Pharma Ltd. technical indicators include Day RSI at 90.73, Day MFI at 100, Day ADX at 67.08. Additional indicators include Commodity Channel Index (CCI) at 102.6. Momentum indicators show Day MACD at 10.2, Day MACD Signal Line at 9.6, DayATR at 2.05. Rate of Change indicators for Parmax Pharma Ltd. include ROC125 at 362.59 and ROC21 at 35.44.
Exponential moving averages include EMA5 at ₹136.3, EMA10 at ₹132.2, EMA12 at ₹130.6, EMA20 at ₹124.6, EMA26 at ₹120.4, EMA50 at ₹105.4, EMA100 at ₹84, EMA200 at ₹64.8. Simple moving averages include SMA5 at ₹136.4, SMA10 at ₹132.8, SMA20 at ₹122.5, SMA30 at ₹116.7, SMA50 at ₹105.1, SMA100 at ₹72.5, SMA150 at ₹58.7, SMA200 at ₹52.4.
Support levels for Parmax Pharma are placed at First Support ₹137.30, Second Support ₹135.50, Third Support ₹134.60. Resistance levels are seen at First Resistance ₹140.00, Second Resistance ₹140.90, Third Resistance ₹142.70. Parmax Pharma Ltd. shareholding pattern shows promoter holding at 30.8%, FII holding at 0%, DII holding at 0%, public holding at 69.2%.
Parmax Pharma Performance
Price Movement
₹137.75
₹139.10
1 Year Performance
Data is not available
Markets Today
Historical Performance
Parmax Pharma Fundamentals
Parmax Pharma Financials
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 8.22 | 3.31 | 4.33 | 2.53 | 1.94 |
| Operating Expense | 7.39 | 4.86 | 4.52 | 4.12 | 2.19 |
| Operating Profit | 0.83 | -1.55 | -0.20 | -1.59 | -0.25 |
| Depreciation | 0.48 | 0.25 | 0.27 | 0.26 | 0.24 |
| Interest | 0.23 | 0.50 | 0.28 | 0.24 | 0.28 |
| Tax | 0 | -1.69 | 0 | 0 | 0 |
| Net Profit | 2.20 | -0.58 | -0.73 | -2.08 | -0.76 |
Parmax Pharma Technicals
Parmax Pharma Ltd. EMA & SMA
₹137.75
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
Parmax Pharma Support and Resistance
Resistance
Support
Technical Indicators
Parmax Pharma Shareholding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 30.8 | 30.8 | 30.8 | 30.8 | 30.8 | 30.8 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 69.2 | 69.2 | 69.2 | 69.2 | 69.2 | 69.2 |
Parmax Pharma Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 12.92 K | 12.92 K | 100.00% |
| Week | 12.92 K | 12.92 K | 100.00% |
| 1 Month | 0 | 0 | undefined% |
| 6 Month | 7.66 K | 8.16 K | 93.87% |
Parmax Pharma SWOT Analysis
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Consistent high performing stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Growth stocks, promoters increasing shareholding
PEG lower than Industry PEG
New 52 week high today
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Turnaround companies- loss to profit QoQ
Growth in Net Profit with increasing Profit Margin (QoQ)
Increasing profits every quarter for the past 3 quarters
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Companies with Zero Promoter Pledge
Highest Recovery from 52 Week Low
Stock with Low PE (PE < = 10)
Top Gainers
New 52 Week High
Stocks Outperforming their Industry Price Change in the Quarter
Parmax Pharma Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Parmax Pharma Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹112.65 | ₹150 | ₹32.50 | ₹504.05 | ₹168.45 | ₹290 |
| % Change | -3.43% | -1.96% | 0.00% | 2.06% | -0.03% | 0.00% |
| Revenue TTM (₹ Cr) | - | - | - | ₹526.28 | - | - |
| Net Profit TTM (₹ Cr) | - | - | - | ₹20.77 | - | - |
| PE TTM | 14.60 | 16.40 | 7.70 | 106.50 | 12.80 | 43.30 |
| 1 Year Return | 11.51 | 27.67 | ||||
| ROCE | - | 34.19 | - | 3.56 | - | - |
Similar Stocks
VINRKLB
Rekvina Laboratories Ltd.
₹ 56.22
+4.99%
VIVIMEDLAB
Vivimed Labs Ltd.
₹ 7.11
-1.93%
CURIS
Curis Lifesciences Ltd.
₹ 191.90
-12.23%
APPL
Aptus Pharma Ltd.
₹ 442.45
+5.00%
AMANTA
Amanta Healthcare Ltd.
₹ 181.00
-3.43%
AHCL
Anlon Healthcare Ltd.
₹ 29.51
+4.98%
PATELCHEM
Patel Chem Specialities Ltd.
₹ 138.95
+4.59%
APL
Asston Pharmaceuticals Ltd.
₹ 94.75
+0.00%
INFLUX
Influx Healthtech Ltd.
₹ 271.95
+0.59%
MEDIORG
Medicamen Organics Ltd.
₹ 24.00
+2.78%
AMRUTANJAN
Amrutanjan Health Care Ltd.
₹ 505.00
-0.77%
ASTONEALAB
Astonea Labs Ltd.
₹ 324.00
+0.00%
AMWILL
Amwill Health Care Ltd.
₹ 43.00
+0.00%
VALIANTLAB
Valiant Laboratories Ltd.
₹ 118.10
-1.42%
SHELTER
Shelter Pharma Ltd.
₹ 52.00
+15.76%
TLL
Trident Lifeline Ltd.
₹ 381.00
+2.97%
DPL
Dipna Pharmachem Ltd.
₹ 4.34
+9.87%
ACHYUT
Achyut Healthcare Ltd.
₹ 5.32
-2.74%
SIGACHI
Sigachi Industries Ltd.
₹ 28.32
-0.70%
WINDLAS
Windlas Biotech Ltd.
₹ 945.50
-0.39%
VINEETLAB
Vineet Laboratories Ltd.
₹ 37.90
+1.20%
CBPL
Chandra Bhagat Pharma Ltd.
₹ 38.20
+0.00%
CHCL
Cian Healthcare Ltd.
₹ 25.95
+0.00%
FAQ's on PARMAX
What is the Market Capitalization of Parmax Pharma Ltd.?
What are the PE and PB ratios for Parmax Pharma Ltd.?
What is the 52-Week High and Low for Parmax Pharma Ltd.?
Who are the major shareholders of Parmax Pharma Ltd.?
Who are the peers of Parmax Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy